NASDAQ OMX

BIMobject® Cloud når ny milstolpe med 500 000 användare

Dela

BIMobject AB ("BIMobject") kan idag meddela att företagets molnplattform BIMobject® Cloud har nått milstolpen 500 000 professionella användare. Med långt över 94 miljoner produktvisningar och 13 miljoner nedladdningar av digitala byggprodukter, så kallade BIM-objekt, bekräftar denna senaste milstolpe företagets position som världens ledande plattform för BIM-objekt för arkitekt-, ingenjörs- och byggindustrin (AEC).  

Tillsammans har de 500 000 registrerade BIM-användarna nu laddat ner fler än 13 miljoner digitala byggprodukter från molnlösningen på bimobject.com. Dessa BIM-objekt har använts i byggprojekt världen över. Sedan dess lansering har BIMobject Cloud besökts av nästan 4,2 miljoner unika besökare och de olika produktfamiljerna har visats över 94 miljoner gånger.

I BIMobject® Cloud får arkitekter, ingenjörer, designers och andra yrkesverksamma inom byggbranschen tillgång till högkvalitativa BIM-objekt från licensierade tillverkare. BIM-objekten kan användas direkt i något av marknadens ledande 3D-, CAD- eller BIM-program. Nedladdningen sker via företagets BIMobject® Apps, eller helt enkelt med hjälp av en vanlig webbläsare. Objekten som BIMobject erbjuder innehåller all den information och de egenskaper som behövs; produktlogik, parametriska beteenden, standarder, klassifikationer och flera nivåer av 2D- och 3D-geometri.

För närvarande finns över 39 000 produktfamiljer från fler än 990 ledande varumärken tillgängliga för nedladdning på BIMobject Cloud. Mer än 270 000 parametriska och konfigurerbara BIM-objekt motsvarar mer än 21 miljoner artiklar.

"Vi inledde året med målet att nå ett antal viktiga milstolpar: 500 000 registrerade användare, 1000 publicerade tillverkare och 100 miljoner produktvisningar. Halvvägs genom året har vi redan nått den första med en halv miljon användare. Vi närmar oss även de andra tidigare än förutspått. Nu siktar vi på att nå en miljon användare innan årsslutet 2019", säger Stefan Larsson, VD och grundare för BIMobject.

För mer information, vänligen kontakta
Louise Otto - presskontakt
Tel: +46 40 - 685 29 00 
E-mail: press@bimobject.com

Om BIMobject AB:

BIMobject AB är med sitt molnbaserade content management system för BIM-objekt, en "game changer" för byggindustrin världen över.

BIMobject är ett innovativt teknologiföretag som ligger i framkant vad gäller digitaliseringen av byggprodukter och material. Detta genom att tillgängliggöra produktinformation som kan omvandlas till kunskap tidigt i BIM-processen. Det gör det möjligt att industrialisera byggindustrin och ha stort inflytande över design, produktval, konstruktion, svinn, energi, kostnader, kvalitet och logistik.

Våra unika lösningar för tillverkare av byggnads- och interiörprodukter erbjuder utveckling, hosting, underhåll, administration och publicering av digitala kopior av tillverkares produkter - BIM-objekt. Webbtjänsterna för digital marknad- och pre-sales som BIMobject Cloud erbjuder, kanaliseras och integreras via appar till CAD/BIM-applikationer för att skapa direkta affärsrelationer och kommunikation världen över.

BIM-objekten integreras i informationsmodellen genom hela processen och beskriver byggnaden och dess delar i detalj, därmed ökar chanserna för att bli föreskriven för de produkter som finns tillgängliga i BIMobject Cloud.

BIMobject® - Vinnare av 2013 Red Herring 100 Global

BIMobject AB (publ) - Nasdaq Stockholm First North - Ticker: BIM 

http://bimobject.com    

Sedermera Fondkommission är bolagets Certified Adviser.




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: BIMobject AB via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Skriv in din e-postadress så får du ett mejl när vi har något nytt att berätta.

Senaste pressmeddelandena från NASDAQ OMX

Barings Supports New Mountain Capital Investment in DRB Systems17.10.2017 16:30Pressmeddelande

CHARLOTTE, N.C., Oct. 17, 2017 (GLOBE NEWSWIRE) -- Barings, one of the world's leading asset management firms, announced today that it served as a Joint Lead Arranger on a Senior Secured Credit Facility to support New Mountain Capital's acquisition of DRB Systems LLC.                                                               Founded in 1984 and based in Akron, Ohio, DRB Systems is the leading provider of turnkey technology solutions used to enhance the operational efficiency of car wash sites across the U.S.  DRB's integrated technology offering includes hardware and software used in point-of-sale and tunnel control systems as well as ancillary modules to support marketing, human resources, and business analytics. "New Mountain Capital is pleased to have completed its investment in DRB Systems," said Jack Qian, Director of New Mountain Capital. Laura Holson, Head of Capital Markets at New Mountain added, "We deeply value Barings' support as a financing pa

Crown Bioscience to Showcase Scientific Expertise in Preclinical Evaluation of Investigational Cancer Compounds17.10.2017 16:12Pressmeddelande

SANTA CLARA, Calif., Oct. 17, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, will showcase their scientific expertise at this year's American Association for Cancer Research's International Conference on Molecular Targets and Cancer Therapeutics (AACR-NCI-EORTC) October 26th through the 30th. CrownBio's scientists will present 13 scientific posters describing their latest research efforts, including generation of novel models for combinatory chemotherapy and immunotherapy studies, creation of 3D screening panels for improved efficacy assessments, demonstration of a checkpoint immunotherapy modulating intestinal microbiota, among other innovative developments in cancer therapeutics and preclinical pharmacology evaluation. On

Oxford Immunotec Schedules Third Quarter 2017 Earnings Release and Conference Call for October 31, 201717.10.2017 15:15Pressmeddelande

OXFORD, United Kingdom and MARLBOROUGH, Mass., Oct. 17, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions, today announced that it plans to release third quarter 2017 financial results prior to market open on Tuesday, October 31, 2017.  Dr. Peter Wrighton-Smith, Chief Executive Officer, and Rick Altieri, Chief Financial Officer, will host a conference call to review the Company's results at 8:00 a.m. Eastern Time the same day. The call will be concurrently webcast. To listen to the conference call on your telephone, please dial (855) 363-5047 for United States callers and +1 (484) 365-2897 for international callers and reference confirmation code 99539511, approximately ten minutes prior to start time.  To access the live audio webcast or subsequent archived recording, visit the Investor Relations se

World Conference on Lung Cancer Tuesday Press Conference: Evidence to Support Innovative Lung Cancer Interventions17.10.2017 08:16Pressmeddelande

YOKOHAMA, Japan, Oct. 17, 2017 (GLOBE NEWSWIRE) -- Today's press conference at the International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer (WCLC) featured groundbreaking findings in the study of both small cell and non-small cell lung cancer. The studies presented covered broad research areas, from confirmation of existing classification criteria to ensuring viability of evidence to supporting the use of specific interventions. Biopsy specimen found to be reliable for evaluating DLL3 expression in small cell lung cancer Small cell lung cancer (SCLC) biopsy specimen was found to be reliable material for evaluating DLL3 expression; high levels of DLL3 in SCLC are correlated with poor survival trends. These results may lead to further evaluation of the scoring system for predicting DLL3-targeted therapeutic efficacy and clinical significance of DLL3 expression in high-grade pulmonary neuroendocrine carcinomas.

New Era Launches Direct-to-Consumer eCommerce Site Built by EPAM and Powered with SAP Hybris17.10.2017 06:01Pressmeddelande

New Site Expands Headwear and Apparel Offering with Immersive, Omnichannel Experience NEWTOWN, Pa., Oct.  17, 2017  (GLOBE NEWSWIRE) -- EPAM Systems, Inc. (NYSE:EPAM), a leading global provider of digital platform engineering and software development services, and New Era, a global headwear brand rooted in sports, today announced the launch of New Era's first direct-to-consumer website, neweracap.com. New Era's B2B business remains strong, and the company is now putting an emphasis on selling its products directly to customers and expanding its offering into the lifestyle market. The new site offers products for seasoned athletes and sports fans, as well as street and lifestyle consumers. "In an age where businesses cannot tolerate lengthy, scope changing technology projects, EPAM quickly established themselves as the standout partner for us to tackle this ambitious initiative," said Lorenz Gan, Global Vice President, Information Technology, New Era. "Whilst this p

CP Kelco Appoints Didier Viala as New President16.10.2017 15:00Pressmeddelande

ATLANTA, Oct. 16, 2017 (GLOBE NEWSWIRE) -- CP Kelco, a leading global producer of specialty hydrocolloid solutions, announced today that Didier Viala has been appointed President, effective October 1, 2017. Viala replaces Donald Rubright, who served as CP Kelco President since 2006 and will retire at the end of 2017. Viala has also joined the CP Kelco Board of Directors. "As a market leader supplying high-quality hydrocolloid products for a range of foods and beverages, consumer products and industrial applications, CP Kelco will continue to invest in capacity additions, new product and applications development, strategic raw material sourcing, quality and safety management, and sustainability initiatives to support our customers' innovation efforts and growth strategies," Viala said. Over the course of more than 25 years with CP Kelco and its predecessor companies, Viala held leadership roles across a broad spectrum of critical areas, including innovat

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum